NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 338 filers reported holding NEOGENOMICS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,313 | -44.5% | 126,123 | -27.4% | 0.00% | 0.0% |
| Q2 2023 | $2,792,645 | +295.2% | 173,780 | +328.1% | 0.00% | – |
| Q1 2023 | $706,707 | +3.8% | 40,592 | -44.9% | 0.00% | – |
| Q4 2022 | $681,006 | +432.0% | 73,702 | +397.0% | 0.00% | – |
| Q3 2022 | $128,000 | -95.6% | 14,829 | -93.8% | 0.00% | – |
| Q1 2022 | $2,896,000 | -19.6% | 238,392 | +125.7% | 0.00% | -100.0% |
| Q4 2021 | $3,603,000 | -37.5% | 105,610 | -11.7% | 0.00% | -50.0% |
| Q3 2021 | $5,766,000 | +128.5% | 119,542 | +114.0% | 0.00% | – |
| Q2 2021 | $2,523,000 | -62.3% | 55,856 | -59.7% | 0.00% | -100.0% |
| Q1 2021 | $6,684,000 | +124.9% | 138,590 | +151.1% | 0.00% | +200.0% |
| Q4 2020 | $2,972,000 | +105.0% | 55,193 | +40.4% | 0.00% | – |
| Q3 2020 | $1,450,000 | +9.8% | 39,298 | -7.8% | 0.00% | -100.0% |
| Q2 2020 | $1,320,000 | -69.9% | 42,600 | -87.8% | 0.00% | -88.9% |
| Q4 2018 | $4,391,000 | – | 348,184 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |